Table 4.

Top ten new deficits by A. incidence among COVID-19 infected individuals and by B. incidence difference between infected individuals and uninfected controls.

A. Incidence, New VA-FI Deficits Among COVID-19 Infected		B. Incidence Difference, New Deficits, COVID-19 Infected vs Uninfected
New Deficit	Incidence	New Deficit	Incidence Difference
Fatigue	8,818 (9.7%)	Fatigue	5.7% (5.4–5.9)
Anemia	6,174 (6.8%)	Muscle Atrophy & Cachexia	3.7% (3.5–3.9)
Muscle Atrophy & Cachexia	5,899 (6.5%)	Lung Disease	3.1% (2.9–3.2)
Gait Abnormality	5,689 (6.2%)	Anemia	2.3% (2.1–2.5)
Arthritis	5,285 (5.8%)	Gait Abnormality	2.0% (1.8–2.2)
Lung Disease	5,193 (5.7%)	Dementia	1.9% (1.7–2.1)
Chronic Pain	4,777 (5.2%)	Chronic Pain	1.6% (1.4–1.8)
Durable Medical Equipment	4,711 (5.2%)	Anxiety	1.6% (1.5–1.8)
Dementia	4,444 (4.9%)	Peripheral Vascular Disease	1.6% (1.4–1.7)
Anxiety	4,405 (4.8%)	Depression & Bipolar Disorder	1.6% (1.4–1.7)